January 18, 2021 |
VBI Vaccines Announces Poster Presentation at EASL 2023
VBI Vaccines Reports First Quarter 2023 Financial Results
VBI Vaccines Appoints Vaughn Himes to Board of Directors
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split